Akshat Jain/LinkedIn
Jul 13, 2026, 15:23
Akshat Jain: 5 Key Clinical Takeaways from ISTH 2026
Akshat Jain, Hematology Pediatric Workforce Task Force at American Society of Hematology, shared a post on LinkedIn:
”’International Society on Thrombosis and Haemostasis (ISTH) 2026 meeting in Paris provided a great platform to interact with colleagues around the world and present our real world case scenario in Bleeding Disorder’s and other research work
Takeaways:
- Gene therapy is alive and well and powerful advances in the field coming in the next 5 years – Wolfgang Miesbach
- Novel drug delivery is going to change how we offer therapies . Inno8 was very exciting – Novo Nordisk
- Von Willebrand Disease : underserved population such as young children and women with bleeding have amazing new options that are looking beyond ‘Just Bleeding’. Sarcopenia, anemia and fatigue with therapies new target to study Octapharma
- Safety of Rebalancing agents assessed and more real world data very promising – Pfizer
- I.T.P. : subcutaneous therapy once a week targeting pro coagulation like protein C and S would add another layer of protection in addition to Rizlabrutinib from Sanofi
Women with blood disorders is finding more representation in novel therapeutics and personalized therapies Angela Weyand, Flora Peyvandi.”

Stay updated with Hemostasis Today.
-
Oct 18, 2026, 07:49Matthew Hazell: Molecular Matching and the Future of Transfusion Practice
-
Oct 18, 2026, 07:05Behnood Bikdeli: Vasculearn Network Highlights Expert Perspectives on PE Risk Stratification and Advanced Therapies
-
Oct 18, 2026, 06:27Gregory Makris: NEJM Study Supports Earlier Catheter-Directed Intervention in Intermediate-High–Risk PE
-
Oct 18, 2026, 06:26Danny Hsu: BLOOD 2026 Return to Aotearoa
-
Oct 18, 2026, 02:43Priya Sriskandarajah: Diagnosis and Management of PV and JAK2-Unmutated Erythrocytosis
-
Oct 18, 2026, 02:41C. Michael Gibson: A Meta-Analysis of DOACs and DAPT After Left Atrial Appendage Closure
-
Oct 18, 2026, 02:27What Hematologists Should Remember About the Person Behind the Platelet Count – ASH
-
Oct 18, 2026, 01:44Marta Velia Antonini: How to Deliver CRRT during ECMO?
-
Oct 18, 2026, 01:19Aamir Saeed: Anticoagulation, Cirrhosis, and Other Risk Factors for Post-ERCP Bleeding